rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2006-7-17
|
pubmed:abstractText |
Pinusolide (1), a known platelet-activating factor (PAF) receptor binding antagonist, was synthesized from lambertianic acid (2), a labdane-type diterpene readily accessible in multigram quantities from the Siberian pine tree. It was shown that 1 not only decreases the proliferation activity of tumor cells at relatively low concentrations but specifically induces apoptosis at 100 microM via the mitochondrial pathway in the Burkitt lymphoma cell line BJAB. Also, using primary lymphoblasts and leukemic cells from children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), a significant DNA fragmentation in pinusolide-treated cells could be detected in an ex vivo apoptosis assay.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0960-894X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4228-32
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16781150-Antineoplastic Agents,
pubmed-meshheading:16781150-Carboxylic Acids,
pubmed-meshheading:16781150-Cell Line,
pubmed-meshheading:16781150-Cell Line, Tumor,
pubmed-meshheading:16781150-Crystallography, X-Ray,
pubmed-meshheading:16781150-DNA Fragmentation,
pubmed-meshheading:16781150-Diterpenes,
pubmed-meshheading:16781150-Dose-Response Relationship, Drug,
pubmed-meshheading:16781150-Drug Design,
pubmed-meshheading:16781150-Humans,
pubmed-meshheading:16781150-Leukemia, Myeloid, Acute,
pubmed-meshheading:16781150-Mitochondria,
pubmed-meshheading:16781150-Models, Chemical,
pubmed-meshheading:16781150-Models, Molecular,
pubmed-meshheading:16781150-Naphthalenes,
pubmed-meshheading:16781150-Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
pubmed:year |
2006
|
pubmed:articleTitle |
Gram-scale synthesis of pinusolide and evaluation of its antileukemic potential.
|
pubmed:affiliation |
Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 Prosp. Akad. Lavrent'eva, Novosibirsk, Russian Federation. schultz@nioch.nsc.ru
|
pubmed:publicationType |
Journal Article
|